Lupus Nephritis Treatment
Lupus Nephritis Treatment
Treatment of lupus nephritis is organised around a simple idea: the inflammation has to be stopped, and then it has to stay stopped. Those are two different jobs, they run on different timescales, and they are done with different intensities of treatment. This page sets out both phases, what sits underneath them permanently, and what is monitored while they are running.
Why treatment comes in two phases
Lupus nephritis is treated in two stages because it behaves in two stages. While the inflammation is active, the priority is speed: the faster the immune attack on the filtering units is brought under control, the less tissue is lost. Once it is under control, the priority changes to steadiness: keeping it under control for long enough that the disease does not come back, without carrying more treatment than is needed to do that.
| Phase | Aim | Timescale |
|---|---|---|
| Induction | Stop the inflammation and bring urine and blood tests back towards normal | Months. The response is assessed against a target agreed at the start |
| Maintenance | Hold the result at the lowest dose that keeps it, and prevent a flare | Years. Stepped down slowly once a sustained period of stable results has passed |
What the phases produce is a response, and the response is described in degrees rather than as success or failure. A complete response means the urine is close to normal and function is stable. A partial response means things have improved but not to the target, which is common and is a reason to keep going rather than a reason to change course. Both are judged over months, because that is the timescale on which this disease answers — a change made after two weeks tells you nothing and costs you the chance to judge the plan you were on.
Induction — stopping the inflammation
Induction means dampening the immune attack hard enough to stop the inflammation that is damaging the filtering units. It is the phase in which treatment is at its most effective, and also at its most demanding on the body.
| Component | What it is for |
|---|---|
| A glucocorticoid | Rapid control of inflammation, started high and then reduced on a written schedule rather than left at the starting dose |
| Mycophenolate or cyclophosphamide | The partner drug that does the sustained immune suppression, so that the steroid dose can come down. The choice between them is a clinical one, made on class, severity, infection risk and future plans |
| A biological agent, in selected cases | Added where standard treatment has not controlled the disease, or where avoiding heavy steroid exposure matters enough to change the first-line choice |
| Blood pressure control, from the start | An ACE inhibitor or angiotensin receptor blocker reduces pressure inside the filtering unit and lowers protein loss, independently of the immune treatment |
During induction the monitoring is close: blood counts, liver and kidney function, and infection surveillance at intervals set by which drugs are being used, rather than left to the next routine appointment. Any fever, any new infection, or any symptom that does not fit should be reported rather than sat on — on these medicines, an infection that is caught early is a very different problem from one that is not.
Maintenance — holding it, for years
Maintenance begins once the inflammation has been brought under control, and it is where a great deal of the long-term outcome is actually decided. Its purpose is not to improve anything further but to prevent the disease from returning while the immune system settles.
What maintenance usually contains is mycophenolate or azathioprine, continued for years at the lowest dose that holds the remission, together with hydroxychloroquine and the blood pressure medicine where they are appropriate. Glucocorticoids are reduced as far as the disease allows and, where possible, eventually stopped — the tapering schedule is written down at the start rather than improvised month by month.
Two things about this phase are worth stating plainly. First, reducing the treatment too early is one of the commonest ways a remission is lost, which is why the reductions follow a period of stable results rather than a feeling of recovery. Second, a reduction is usually made one medicine at a time. Changing two things at once makes it impossible to tell which one caused the change if something goes wrong, and the whole point of a controlled step-down is that the plan remains legible. How far the treatment is eventually reduced is an individual decision, made with the shape of your disease over time, and your team should tell you the period they are working towards.
The base of the regimen: hydroxychloroquine and blood pressure
Two treatments sit underneath everything else, and neither is aimed specifically at the kidney.
Hydroxychloroquine is recommended for essentially everyone with lupus unless there is a reason not to use it. It is not an add-on to fill out the prescription: it reduces the frequency of flares, has favourable effects on clotting and on metabolic risk, and is continued through periods when the disease is quiet. It carries one specific long-term consideration — a small risk of change to the retina — which is managed by an eye examination at the intervals set by your team, with the dose set by body weight. Because the risk is manageable, the answer to it is scheduled screening rather than avoidance.
Blood pressure control is the second permanent element, with an ACE inhibitor or an angiotensin receptor blocker as the usual choice. These lower both the systemic pressure and the pressure inside the filtering unit, and they reduce protein loss independently of the immune treatment. The target is set for your situation, and it is measured properly — including outside the clinic — because a pressure that is only good in the consulting room is not a controlled pressure.
Which agent is used, at which dose, and whether it is appropriate for a particular person — including anyone who is or may become pregnant — is a decision for the treating team rather than something to be inferred from a general page, and availability of individual medicines varies by country.
What is protected along the way
Strong immune suppression treats the kidney and creates problems elsewhere, and most of the work of a good regimen is anticipating them rather than reacting to them.
| Area | What is done |
|---|---|
| Infection | Screening for latent infection before treatment starts, vaccination brought up to date before immunosuppression where possible, and a low threshold for investigating fever during it |
| Bone | Calcium and vitamin D, load-bearing exercise, and a bone-protective medicine where steroid exposure and other risk factors justify it |
| Stomach | Protection where steroids and anti-inflammatory painkillers are used together, and a preference for alternatives to those painkillers wherever possible |
| Blood, liver and kidney | Scheduled blood counts, liver tests and kidney function at intervals set by the drugs being used, not by symptoms |
| Cardiovascular and metabolic risk | Blood pressure, glucose and lipids followed over time, since both lupus and steroids raise that risk and the consequences arrive slowly |
| Clotting | Anticoagulation where antiphospholipid antibodies or a nephrotic pattern of protein loss make a clot a real possibility |
| Eyes | Retinal screening on the schedule set for hydroxychloroquine, so that any change is found while it is reversible |
Two habits reduce what any of this has to catch. Keeping a written list of what you take, including anything bought without a prescription and any herbal preparation, means interactions can be checked before something happens rather than after. And reporting symptoms early — a fever, a new medicine started by someone else, a change in vision, a new painkiller — is what turns most of these from an emergency into an adjustment.
If function falls far: dialysis and transplantation
Where filtration falls to the point that the kidneys can no longer do their work, replacement treatment is available and it is planned rather than improvised. That planning starts well before it is needed, because the preparatory steps take time and because arriving at dialysis through an emergency is worse for nearly everyone.
| Option | What planning involves |
|---|---|
| Haemodialysis | Vascular access created and allowed to mature in advance, so that the first treatment is not through an emergency line |
| Peritoneal dialysis | A catheter placed ahead of need, and training done while there is still time to learn rather than while unwell |
| Transplantation | Assessment and waiting-list steps begun early, with the transplant timed to a period when the lupus is quiet, because activity at the time of transplant affects the outcome |
| Conservative care | Where replacement is not wanted or not appropriate, a plan built around symptom control and quality of life, stated as a legitimate choice rather than a failure |
Two things are worth saying to anyone who reads this section looking for a prediction. Most people with lupus nephritis never reach this point, because the treatments above control the disease in a large share of cases. And if they do, lupus is not a barrier to transplantation: it is performed in people with lupus, with the timing chosen deliberately and recurrence in the transplanted kidney uncommon. What matters is that the possibility is discussed years early, so that decisions are made calmly and in the right order. The preparatory steps are set out on the living-with-it page.
Living well on treatment
Most of what protects the kidney between appointments happens outside the hospital, and it is unglamorous: taking what was prescribed on the day it was prescribed, keeping the appointments, and noticing change early.
Practical points that make a measurable difference. Keep salt intake down, because it acts on the same blood pressure that is doing half the damage. Avoid anti-inflammatory painkillers such as ibuprofen and diclofenac where possible, and ask before taking anything new, including supplements and herbal preparations. Stop smoking, which accelerates kidney and cardiovascular damage independently of everything else here. Protect against ultraviolet exposure, which is a well-recognised trigger of lupus activity. Move regularly, within what your energy allows. And take fatigue seriously rather than pushing through it — it is both a symptom of activity and a consequence of treatment, and it is worth reporting rather than enduring.
Pregnancy deserves its own line rather than a footnote: it is usually possible, and it is planned rather than permitted. The usual condition is that the disease has been quiet for a sustained period before conception, with medicines reviewed in advance so that anything unsuitable is changed before rather than after. What that planning involves is set out on the living-with-it page.